Apotex and Strides to merge Australia generics business
15-05-2018
Eli Lilly targets more than 30 generics in Effient patent case
17-03-2014
PENpics Studio / Shutterstock.com
Azurity Pharmaceuticals has sued Massachusetts drug company Bionpharma, claiming that its generic of Azurity’s Epaned product infringes on a brand new patent.
You need a subscription to continue reading this content.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Azurity Pharmaceuticals Bionpharma, Enalapril Maleate, US District Court for the District Of Delaware, FDA
